Literature DB >> 22318583

Drug bests cystic-fibrosis mutation.

Heidi Ledford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318583     DOI: 10.1038/482145a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Targeting the low-hanging fruit of neurodegeneration.

Authors:  Amanda R Mason; Adam Ziemann; Steven Finkbeiner
Journal:  Neurology       Date:  2014-10-14       Impact factor: 9.910

Review 2.  The Convergence of Systems and Reductionist Approaches in Complex Trait Analysis.

Authors:  Evan G Williams; Johan Auwerx
Journal:  Cell       Date:  2015-07-02       Impact factor: 41.582

3.  Saliva as a potential tool for cystic fibrosis diagnosis.

Authors:  Aline Cristina Gonçalves; Fernando Augusto de Lima Marson; Regina Maria de Holanda Mendonça; José Dirceu Ribeiro; Antonio Fernando Ribeiro; Ilma Aparecida Paschoal; Carlos Emílio Levy
Journal:  Diagn Pathol       Date:  2013-03-19       Impact factor: 2.644

Review 4.  Targeted therapies to improve CFTR function in cystic fibrosis.

Authors:  Malcolm Brodlie; Iram J Haq; Katie Roberts; J Stuart Elborn
Journal:  Genome Med       Date:  2015-09-24       Impact factor: 11.117

5.  Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis.

Authors:  Zhichao Liu; Jürgen Borlak; Weida Tong
Journal:  Genome Med       Date:  2014-12-02       Impact factor: 11.117

6.  The Promise and the Hype of 'Personalised Medicine'.

Authors:  Tim Maughan
Journal:  New Bioeth       Date:  2017-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.